Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Piedmont Office Realty Trust, Inc. (PDM - Snapshot Report), a real estate investment trust (REIT), recently inked a 12-year lease agreement with Catamaran Corporation (CTRX - Snapshot Report) to lease full space of a Chicago-based property – Windy Point II. The transaction was in line with the company’s policy of signing long-term leases with high-quality tenants in core strategic markets.
Situated in the northwest suburb of Chicago, Windy Point II is an 11-storey building spanning around 300,686 square foot. The property is in close proximity to major state and interstate highways and Chicago’s O’Hare International Airport.
Moreover, the property also has convenient access to high-end restaurants, hotels, daycare facilities, banks and health clubs. The property is under the ownership and management of Jones Lang LaSalle Inc. (JLL - Analyst Report).
Catamaran Corporation (formerly known as SXC Health Solutions) engages in pharmacy benefit management services and healthcare information technology solutions to the healthcare benefits management industry in North America. The company was recently formed by amalgamation of SXC Health Solutions and Catalyst Health Solutions in 2012. The company is scheduled to relocate its headquarters situated in Lisle, Illinois to Windy Point II in the spring of 2013.
Subsequent to the end of the second quarter of 2012, Piedmont Office Realty signed long-term lease agreements with two renowned firms – Guidance Software, Inc. (GUID - Snapshot Report) and Schlumberger Limited (SLB - Analyst Report) – to lease more than 100,000 square feet of office space. The properties were based in the company’s core markets – California and Texas.
Piedmont Office Realty deals in premium Class A office properties located primarily in the ten largest U.S. office markets including Chicago, Washington, D.C., New York, Dallas, Los Angeles and Boston. As of June 30, 2012, the company’s portfolio comprises of 74 wholly-owned office buildings spanning over 20 million rentable square feet.
The company recently reported second-quarter 2012 FFO (funds from operations) of 21 cents, missing the Zacks Consensus Estimate by 12 cents. We presently have a long-term Neutral recommendation on the stock. However, it carries a Zacks #2 Rank (a short-term Buy rating).
Note: FFO, a widely accepted and reported measure of the performance of REITs, is derived by adding depreciation, amortization and other non-cash expenses to net income.
Get the full Snapshot Report on PDM - FREE
Get the full Snapshot Report on CTRX - FREE
Get the full Analyst Report on JLL - FREE
Get the full Analyst Report on SLB - FREE
Get the full Snapshot Report on GUID - FREE